BellRing Brands Q4 Earnings Slip, But Sales Improve; Stock Up Over 16% In Pre-Market

BellRing Brands (BRBR) reported Q4 2026 earnings of $35.6M ($0.31/share), down from $59.6M ($0.48/share) a year ago. Sales rose to $692M, up from $648.2M, driven by volume growth. Premier Protein sales increased 7.1%. The company expects fiscal 2027 adjusted EBITDA of $310M-$350M and sales of $2.32B-$2.42B. BRBR stock rose 16.21% in pre-market trading.

Original reporting
Published Nov 18, 2026, 1:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 1:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BellRing Brands Q4 Earnings Slip, But Sales Improve; Stock Up Over 16% In Pre-Market — source image
Decision brief

The 30-second read

$BRBRNeutralMed
01

Why it matters

Traders will likely focus on the gap between rising sales and falling profitability, and whether the FY2027 adjusted EBITDA and net sales ranges imply margin stabilization after the inventory-related headwind.

02

Market read

A same-day earnings and guidance print with explicit FY2027 ranges, plus a large pre-market move, creates a tradable setup around margin expectations.

03

What to watch

The article highlights price/mix decline (8.1% lower) alongside volume growth, which can foreshadow weaker profitability if promotional intensity persists.

Relevance 7/10Novelty 4/10Timing: pre-market today

Background

BellRing Brands is a consumer brands company with a key product line in Premier Protein; this is its Q4 FY2026 earnings update and FY2027 outlook.

Company-level read

Ticker impact

$BRBRNeutralHigh confidence
Context

BellRing Brands reported Q4 FY2026 net profit of $35.6M vs $59.6M prior year, while net sales rose to $692M, plus FY2027 EBITDA and sales guidance.

Expected impact

Likely near-term support from the sales increase and provided FY2027 guidance, but upside may be capped by the earnings and EBITDA decline.

Evidence & confidence

The article contains both the earnings deterioration (profit, operating income, adjusted EBITDA, COGS) and the offsetting positives (net sales growth, volume gains, and explicit FY2027 adjusted EBITDA and net sales ranges).

Market effects

Signals ongoing margin pressure in consumer packaged goods/health nutrition brands, even when volumes hold up.

Primarily US consumer staples sentiment, with limited direct regional spillover implied by the single-company print.

Low, as the disclosure is company-specific and not tied to global macro or cross-border policy changes.

Counterpoint

The pre-market pop may overreact to revenue growth and guidance ranges, while the underlying margin deterioration (higher COGS, inventory headwind) could reassert itself in subsequent quarters.

Key entities

  • BellRing Brands, Inc.

    Reported Q4 FY2026 earnings decline with sales growth, and provided FY2027 adjusted EBITDA and net sales guidance.

  • Premier Protein

    Premier Protein net sales increased, driven by volume growth but with price/mix decline.

Related articles

$BRBRMed

BellRing (BRBR) Q4 2026 Earnings Call Transcript

BellRing (BRBR) reported Q4 2026 adjusted EBITDA of $66M, within guidance. The company highlighted strengths in its Premier Protein brand and RTD shake category growth (11% in 2026) but outlined opportunities for improved execution, cost savings, and agility. For 2027, BellRing expects net sales to be up 1% to down 3%, with adjusted EBITDA improvements from pricing and cost initiatives, though facing inflationary pressures.

$BRBRMed

BellRing Brands Inc (BRBR) (Q4 2026) Earnings Call Highlights: Sales Beat, Margin Reset

BellRing Brands (BRBR) reported Q4 adjusted gross margin of 20.1%, down from 29.7% a year ago, due to cost inflation and inventory charges. The company expects fiscal 2027 net sales to be up 1% to down 3%, with Premier RTD consumption growth in mid-single digits. BellRing withdrew its long-term financial outlook, citing a reset of expectations and will provide an updated outlook in Q2 2027.

$BRBRMed

What BellRing Brands (BRBR) Said on Its Q4 Earnings Call

BellRing Brands (BRBR) expects Premier shake consumption to grow in the mid-single digits, with net sales ranging from a 2% decline to 2% growth. Management forecasts high-single-digit commodity inflation and low-to-mid-teens growth in Premier shake consumption for Q1. The company plans cost cuts of at least $100 million over three years and aims to strengthen distribution. Operating cash flow was $126 million in fiscal 2026, with net leverage at 3.6 times.

$BRBRMedAI 8/10

BellRing Brands Stock Jumps 19% Despite Lower Q4 Earnings

BellRing Brands (BRBR) stock rose 19.22% to $13.12 despite lower Q4 earnings. Net income fell to $35.6M ($0.31/share) from $59.6M ($0.48/share) YoY, while sales increased to $692M. The company forecasts fiscal 2027 sales of $2.32B-$2.42B and adjusted EBITDA of $310M-$350M.

$BRBRMedAI 8/10

BellRing Brands: Fiscal Q4 Earnings Snapshot

BellRing Brands Inc. (BRBR) reported fiscal Q4 earnings of $35.6M, or 31 cents per share, beating analyst expectations of 21 cents. Revenue was $692M, also exceeding forecasts. Full-year profit was $147.4M on revenue of $2.4B. The company expects FY revenue between $2.32B and $2.42B. BRBR shares have fallen 59% YTD and 57% over the past year.